Sign Up Today and Learn More About Affect Therapeutics Stock
Invest in or calculate the value of your shares in Affect Therapeutics or other pre-IPO companies through EquityZen's platform.
Affect Therapeutics Stock (AFTH)
Affect Therapeutics is using mobile technology to revolutionize stimulant addiction recovery.
About Affect Therapeutics Stock
Founded
2020
Headquarters
New York, NY, US
Industries
Software, Artificial Intelligence, Data and Analytics
Affect Therapeutics Press Mentions
Stay in the know about the latest news on Affect Therapeutics
Virtual Care Drives Rise In Addiction Treatment Startup Funding
news • May 29, 2024
Affect Therapeutics Secures $16M for Digital Addiction ...
medcitynews • Dec 28, 2023
McLean addiction treatment startup Affect Therapeutics raises $16M to fuel U.S. expansion
bizjournals • Jul 15, 2023
Affect Raises $16M As Addiction-Related Financings Hold Strong
news • Jul 13, 2023
This Startup Just Raised $6 Million For An App That Helps Treat Addiction
forbes • Jun 02, 2022
Affect Therapeutics Management
Leadership team at Affect Therapeutics
Co-founder & Executive Chairman
Jeff De Flavio
Co-founder & Head of Product
Rachel Lin
Join now and verify your accreditation status to gain access to:
- Affect Therapeutics current valuation
- Affect Therapeutics stock price
- Available deals in Affect Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading Affect Therapeutics Stock
How to invest in Affect Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Affect Therapeutics through EquityZen funds. These investments are made available by existing Affect Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Affect Therapeutics stock?
Shareholders can sell their Affect Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
